Janet Rae has over 25 years regulatory affairs experience in biotechnology and pharmaceutical development, focusing on rare diseases including 3 years in the gene therapy space. At Ultragenyx, she leads the development and execution of regulatory strategy including direct interface with regulatory agencies worldwide. Prior to Ultragenyx, she held similar regulatory leadership positions at Dimension Therapeutics, Shire and PAREXEL. Janet holds a BA in Business Administration and RAC since 2002.